You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信邦製藥(002390.SZ):出售中肽生化及康永生物各100%股權事項已執行完畢
格隆匯 12-22 18:02

格隆匯 12 月 22日丨信邦製藥(002390.SZ)公佈,公司第七屆董事會第二十一次會議及2020年第二次臨時股東大會審議並通過了《關於出售全資子公司股權暨關聯交易的議案》,同意公司將中肽生化有限公司100%股權及康永生物技術有限公司100%股權轉讓給泰德醫藥(浙江)有限公司(“泰德醫藥”)。

公司於2020年7月14日披露了《關於出售全資子公司股權的進展公告》,並於近日收到泰德醫藥支付的第二筆股權轉讓款合計人民幣3.675億元。至此此次出售全資子公司股權的轉讓款全部收妥,此次股權轉讓事項已執行完畢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account